Hakutulokset - Lin ZOU
- Näytetään 1 - 4 yhteensä 4 tuloksesta
-
1
"Meaningful Human Control in Artificial Intelligence": Practical Dilemmas of the Consensus Principle in Artificial Intelligence Tekijä Lin ZOU, Yonghui MA
Julkaistu 2025-02-01The concept of "meaningful human control in artificial intelligence" has been proposed in the context of artificial intelligence (AI) development, emphasizing human oversight over AI systems' autonomous decision-making. While this concept has gradually become a widely accepted guiding...
Hae kokoteksti
Artikkeli -
2
A nondestructive method based on absorption of polychromatic neutron beam for monitoring internal gas of sealed container Tekijä Xinxi Li, Bo Li, Yun Wang, Liang Chen, Xiaoling Xiong, Jie Chen, Lin Zou, Chaoqiang Huang, Dong Liu
Julkaistu 2025-06-01Current work introduces a non-destructive testing method for evaluating the gas retention and internal pressure of sealed containers. Pulsed polychromatic neutrons of time-of-flight (TOF) neutron reflectometer Diting at the China Mianyang research reactor (CMRR) were utilized as the probe. By analyz...
Hae kokoteksti
Artikkeli -
3
Shade stress decreases stem strength of soybean through restraining lignin biosynthesis Tekijä Wei-guo LIU, Sajad Hussain, Ting LIU, Jun-lin ZOU, Meng-lu REN, Tao ZHOU, Jiang LIU, Feng YANG, Wen-yu YANG
Julkaistu 2019-01-01Lodging is the most important constraint for soybean growth at seedling stage in maize-soybean relay strip intercropping system. In the field experiments, three soybean cultivars Nandou 032-4 (shade susceptible cultivar; B1), Jiuyuehuang (moderately shade tolerant cultivar; B2), and Nandou 12 (shade...
Hae kokoteksti
Artikkeli -
4
Therapeutic potential of T-cell receptor targeting the HLA-A*11:01-restricted KRASG12V neoantigen without cross-recognition of the self-antigen RAB7B in solid tumors Tekijä Wang Wang, Jingjing Huang, Yanan Hao, Lin Zou, Xiaxia Han, Tong Chen, Meiying Shen, Bozhi Wang, Luo Li, Siyin Chen, Shengchun Liu, Xiaojian Han, Aishun Jin
Julkaistu 2025-07-01Background Public neoantigens, including KRAS, TP53, and PIK3CA mutations, which are shared across various tumor types, have demonstrated significant immunogenicity and offer great promise for cancer immunotherapy. Clinical trials targeting these public neoantigens have yielded encouraging results,...
Hae kokoteksti
Artikkeli